Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Cell Cycle. 2023 Apr;22(7):758-776. doi: 10.1080/15384101.2022.2154543. Epub 2022 Dec 8.
Circular RNAs (CircRNAs) are reported to exert vital regulatory roles in the occurrence and development of various human malignancies, including non-small cell lung cancer (NSCLC). Bioinformatics methods identified the down-regulation of circSCN8A (circBase ID: hsa_circ_0026337) in NSCLC tissues. However, its biological functions and molecular mechanisms in NSCLC remain unknown. In this study, we found that circSCN8A expression was down-regulated in NSCLC tissues and cells. Low circSCN8A expression was positively associated with aggressive clinicopathological characteristics and poor prognosis in NSCLC patients. CircSCN8A suppressed cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) and blocked tumor growth . Moreover, circSCN8A promoted cell ferroptosis in NSCLC. Mechanistically, circSCN8A acted as a competing endogenous RNA (ceRNA) by sponging miR-1290 to enhance the expression of long-chain acyl-CoA synthetase-4 (ACSL4). Furthermore, the knockdown of ACSL4 or overexpression of miR-1290 reversed the effect of circSCN8A on facilitating ferroptosis and inhibiting cell proliferation and metastasis. In summary, circSCN8A represses cell proliferation and metastasis in NSCLC by regulating the miR-1290/ACSL4 axis to induce ferroptosis. Thus, circSCN8A may represent a promising therapeutic target against NSCLC.
环状 RNA(circRNAs)被报道在多种人类恶性肿瘤的发生和发展中发挥重要的调节作用,包括非小细胞肺癌(NSCLC)。生物信息学方法鉴定出 NSCLC 组织中 circSCN8A(circBase ID:hsa_circ_0026337)的下调。然而,其在 NSCLC 中的生物学功能和分子机制尚不清楚。在本研究中,我们发现 circSCN8A 在 NSCLC 组织和细胞中表达下调。circSCN8A 低表达与 NSCLC 患者侵袭性临床病理特征和不良预后呈正相关。circSCN8A 抑制细胞增殖、迁移、侵袭和上皮间质转化(EMT),并阻断肿瘤生长。此外,circSCN8A 促进 NSCLC 细胞铁死亡。机制上,circSCN8A 通过海绵吸附 miR-1290 作为竞争性内源性 RNA(ceRNA),增强长链酰基辅酶 A 合成酶 4(ACSL4)的表达。此外,ACSL4 的敲低或 miR-1290 的过表达逆转了 circSCN8A 促进铁死亡和抑制细胞增殖和转移的作用。总之,circSCN8A 通过调节 miR-1290/ACSL4 轴诱导铁死亡,抑制 NSCLC 细胞增殖和转移。因此,circSCN8A 可能成为 NSCLC 有前途的治疗靶点。